Kallikrein, kininogen and kinins in control of blood pressure.
Plasma kallikrein releases bradykinin when activated by gram-negative septicemia or irreversible hemorrhagic shock. Pancreatitis releases glandular kallikrein causing hypotension and increased vascular permeability. Bradykinin in the brain produces hypertension. Renal kallikrein is released by high arterial pressure, vasodilators, low doses of noradrenaline, angiotensin II, mineralocorticoids and rapid volume expansion. It has a biphasic relation to sodium excretion. In essential hypertension, kallikrein release into the blood and urine is low and facilitates hypertension. High renin in Bartter's syndrome is balanced by high PGE and kallikrein without hypertension.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001477:Bartter Syndrome / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007022:Hypotension / Q000503:physiopathology; D007610:Kallikreins / Q000494:pharmacology / Q000502:physiology*; D007668:Kidney / Q000503:physiopathology; D007704:Kininogens / Q000502:physiology*; D007705:Kinins / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D012083:Renin / Q000502:physiology; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology
D007704:Kininogens; D007705:Kinins; D000804:Angiotensin II; D012964:Sodium; D007610:Kallikreins; D012083:Renin; D009638:Norepinephrine